Science & Technology
When Ideas Come Together, People Get Better.
MAP Pharmaceuticals takes an integrated approach to innovation in medicine by focusing not only on enhancing a drug’s pharmacological profile, thereby improving its efficacy and safety, but also on the best ways to administer the drug and to target the therapy to the affected area in order to improve its performance.
First, we focus on proven drugs that have a history of safety and efficacy, but that have identified shortcomings, such as a narrow therapeutic window. By applying our proprietary particle creation and formulation technologies, we develop novel forms of proven drugs engineered for enhanced administration.
Next, we innovate delivery systems designed to optimize a drug candidate’s clinical performance. We develop, engineer and manufacture aerosol delivery devices, including our TEMPO® inhaler, which have the potential to provide greater deposition in the lung and provide consistent dosing.
Finally, we target therapies to appropriate receptors to create drug products with potentially enhanced pharmacological profiles relative to the parent drugs to improve efficacy and reduce side effects.
We believe that the combination of our various drug particle creation, formulation, delivery and targeting technologies add up to a significant competitive advantage in bringing new therapies to market to address areas of unmet need in neurology.